Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
26.75    0.00 (0.00%)
Bid:
26.50
Ask:
27.00
Spread: 0.50 (1.887%)
Market Cap: £134.69m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Long Term Incentive Plan Awards

6 Mar 2018 07:00

RNS Number : 7530G
Duke Royalty Limited
06 March 2018
 

6 March 2018

Duke Royalty Limited("Duke Royalty", "Duke" or the "Company")

Long Term Incentive Plan ("LTIP") awards

 

Duke Royalty Limited (AIM: DUKE) announces that the Company's Remuneration Committee has approved the following Performance Share Awards ("PSA's") under the Company's Long Term Incentive Plan ("LTIP"). The LTIP framework was detailed within the Company's admission document which was published on 20 March 2017 as was to be put into place post Admission. The Board has determined the issuance of the shares pursuant to part 5 of the admission document can now be issued as the LTIP has been approved and there are no close period restrictions.

The PSA's for the financial year to 31 March 2017 are as follows:

Neil Johnson

500,000 ordinary shares

Charlie Cannon-Brookes

350,000 ordinary shares

Justin Cochrane

175,000 ordinary shares

 

The PSA's vest after a period of three years and are subject to various performance conditions outlined in the admission document and set by the Remuneration Committee, all in accordance with the LTIP rules. The LTIP Awards will be subject to a performance condition based 50 per cent. on total shareholder return ("TSR") and 50 per cent. on total cash available for distribution per share ("TCAD per Share"). TSR can be defined as the returns generated by shareholders based on the combined value of the dividends paid out by the Company and the share price performance over the period in question.

Going forward PSA's will typically be announced within weeks after the Company's financial year results.

 

About Duke Royalty

Headquartered in Guernsey, Duke Royalty Limited provides alternative financing solutions to a diversified range of businesses in Europe and abroad. Duke Royalty's experienced team and exclusive partnership provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders.

Duke Royalty is listed on the AIM market under the ticker DUKE. For more information, visit dukeroyalty.com.

For further information:

Duke Royalty Limited

Neil Johnson / Charlie Cannon-Brookes

 

+44 (0) 1481 741 240

 

 

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson / Samantha Harrison / Carolyn Sansom

 

+44 (0) 20 7383 5100

 

 

Cenkos Securities plc (Joint Broker)

Julian Morse / Michael Johnson

 

+44 (0) 207 397 8900

 

 

Mirabaud Securities Limited (Joint Broker)

Peter Krens / Edward Haig-Thomas

 

+44 (0) 20 3167 7222

 

 

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

END

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Neil Johnson

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Duke Royalty Limited

 

b)

 

LEI

 

 

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

 

GG00BYZSSY63

 

 

Identification code

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Placing Shares pursuant to the Fundraising

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

N/A

500,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

6 March 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Charlie Cannon-Brookes

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Duke Royalty Limited

 

b)

 

LEI

 

 

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

 

GG00BYZSSY63

 

 

Identification code

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Placing Shares pursuant to the Fundraising

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

N/A

350,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

6 March 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Justin Cochrane

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Duke Royalty Limited

 

b)

 

LEI

 

 

213800GUTKPSJ39SER44

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

 

GG00BYZSSY63

 

 

Identification code

 

 

 

b)

 

Nature of the transaction

 

 

Purchase of Placing Shares pursuant to the Fundraising

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

N/A

175,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

6 March 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVABRWAAORAR
Date   Source Headline
23rd Mar 20175:00 pmRNSRe-Admission and First Day of Dealings
22nd Mar 20173:45 pmRNSSch 1 Update - Duke Royalty Limited
20th Mar 20179:35 amRNSSch 1 Update - Duke Royalty Limited
17th Mar 20176:17 pmRNSResult of Fundraising
16th Mar 20175:03 pmRNSProposed Placing and Subscription
21st Feb 201711:25 amRNSSch 1 Update - Duke Royalty Limited
1st Feb 201711:00 amRNSSchedule 1 - Duke Royalty Limited
11th Jan 20177:01 amRNSAppointment of Chief Investment Officer
11th Jan 20177:00 amRNSChange of Advisors and Operational Update
17th Nov 20169:00 amRNSUnaudited interim results
1st Sep 201612:02 pmRNSResult of AGM
25th Jul 20167:00 amRNSFinal Results
29th Mar 20161:32 pmRNSSale of investments
7th Mar 20167:00 amRNSBoard Changes and Corporate Update
3rd Feb 20167:00 amRNSDirector/PDMR Shareholding
19th Jan 20169:55 amRNSChange of Adviser
14th Dec 201511:40 amRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim results
29th Oct 20157:00 amRNSHolding(s) in Company
29th Oct 20157:00 amRNSCorrection: Appointment and Issue of Shares
28th Oct 20157:00 amRNSMr Justin Cochrane Appointment and Issue of Shares
12th Oct 20155:16 pmRNSHolding(s) in Company
17th Sep 20153:40 pmRNSFormation of Healthcare Investment Committee
14th Sep 201512:41 pmRNSHolding(s) in Company
11th Sep 20157:00 amRNSDirector share purchase
10th Sep 201512:00 pmRNSResult of AGM
7th Sep 20159:15 amRNSGrant of options
7th Sep 20157:00 amRNSPlacing
7th Sep 20157:00 amRNSCollaboration with Oliver Wyman
4th Aug 201512:21 pmRNSChanges to NAV Reporting
27th Jul 20154:12 pmRNSResults for the year ended 31 March 2015
16th Jun 201511:36 amRNSResult of EGM
10th Jun 201511:21 amRNSHolding(s) in Company
2nd Jun 20151:57 pmRNSHolding(s) in Company
28th May 201511:00 amRNSEGM, proposed changes to board & investing policy
26th May 20159:58 amRNSHolding(s) in Company
26th May 20159:57 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
22nd May 20155:15 pmRNSRepayment of zero dividend preference shares
20th May 20157:00 amRNSPlacing
15th May 201511:08 amRNSSale of investment
20th Apr 20155:36 pmRNSNet Asset Value(s)
19th Jan 20154:27 pmRNSNet Asset Value(s)
30th Dec 20143:07 pmRNSInterim Results
9th Dec 20145:23 pmRNSNet Asset Value
3rd Nov 20147:00 amRNSChange of administrator and registered address
22nd Oct 20147:00 amRNSNet Asset Value(s)
20th Aug 20141:54 pmRNSResult of AGM
24th Jul 20147:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.